Product Details for NDA 021703
PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Marketing Status: Prescription
3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Prescription
N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Prescription
5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Prescription
N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.44GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Prescription
3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Prescription
N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Prescription
N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Marketing Status: Discontinued
3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Marketing Status: Discontinued
3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Marketing Status: Discontinued
N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Discontinued
5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Discontinued
N/A/1000ML;N/A/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Discontinued
5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2.03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Discontinued
3.68GM/1000ML;N/A/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Discontinued
N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Marketing Status: Prescription
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021703
Product Number: 011
Approval Date: Oct 10, 2008
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
Proprietary Name: PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021703
Product Number: 011
Approval Date: Oct 10, 2008
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Prescription
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021703
Product Number: 006
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
PRISMASOL BGK 2/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
Proprietary Name: PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021703
Product Number: 006
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Prescription
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL BGK 2/0 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021703
Product Number: 002
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
Proprietary Name: PRISMASOL BGK 2/0 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021703
Product Number: 002
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Prescription
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021703
Product Number: 003
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
Proprietary Name: PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021703
Product Number: 003
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.44GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Prescription
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.44GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021703
Product Number: 015
Approval Date: Oct 10, 2008
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
Proprietary Name: PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.44GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021703
Product Number: 015
Approval Date: Oct 10, 2008
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Prescription
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021703
Product Number: 004
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
Proprietary Name: PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021703
Product Number: 004
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Prescription
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021703
Product Number: 014
Approval Date: Oct 10, 2008
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
Proprietary Name: PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021703
Product Number: 014
Approval Date: Oct 10, 2008
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Marketing Status: Discontinued
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 010
Approval Date: Oct 10, 2008
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
Proprietary Name: PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 010
Approval Date: Oct 10, 2008
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Marketing Status: Discontinued
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 012
Approval Date: Oct 10, 2008
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
Proprietary Name: PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 012
Approval Date: Oct 10, 2008
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Marketing Status: Discontinued
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 013
Approval Date: Oct 10, 2008
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
PRISMASOL BGK 4/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
Proprietary Name: PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 013
Approval Date: Oct 10, 2008
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Discontinued
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL BGK 4/0 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 005
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
Proprietary Name: PRISMASOL BGK 4/0 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 005
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Discontinued
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 008
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
PRISMASOL BK 0/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
Proprietary Name: PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 008
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
N/A/1000ML;N/A/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Discontinued
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL BK 0/0 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: N/A/1000ML;N/A/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 007
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
Proprietary Name: PRISMASOL BK 0/0 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: N/A/1000ML;N/A/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 007
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2.03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Discontinued
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2.03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 001
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
Proprietary Name: PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2.03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 001
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
3.68GM/1000ML;N/A/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Marketing Status: Discontinued
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Proprietary Name: PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.68GM/1000ML;N/A/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 009
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.68GM/1000ML;N/A/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N021703
Product Number: 009
Approval Date: Oct 25, 2006
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information